Benitec Biopharma (BNTC) Stock Price
Benitec Biopharma Price
Revenue at Benitec Biopharma has contracted by 18.9% per year over the past 17 years to 80,000.00 USD. Benitec Biopharma's net margin stands at -24,450.0%, down from 24.7% several years earlier. Benitec Biopharma currently offers a dividend yield of about 8.51%. Analysts set a median price target of 20.50 USD, implying 128.0% above the current price. Of 13 analysts, 12 rate the stock a buy — an overall Buy consensus.
Benitec Biopharma stock price
Benitec Biopharma business model & stock analysis
Frequently asked questions about Benitec Biopharma
Analysts currently set an average price target of 20.50 USD for the Benitec Biopharma stock (median: 20.50 USD), implying +128.0 % versus the latest price. The consensus is based on 13 analyst ratings.
13 analysts currently rate the Benitec Biopharma stock: 12 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Benitec Biopharma to generate revenue of 25.43 M USD and earnings per share of -0.98 USD.
Converted at the current exchange rate, the Benitec Biopharma share trades at 8.02 EUR (8.99 USD).
The Benitec Biopharma share (BNTC) is listed on 3 stock exchanges, including: NASDAQ (BNTC), Frankfurt (BJ93.F), München (BJ93.MU).
The expected revenue of Benitec Biopharma is 25.43 M USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Benitec Biopharma is -35.42 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Benitec Biopharma is currently -9.19. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Benitec Biopharma stock.
The price-to-sales ratio (P/S) of Benitec Biopharma is currently 12.80. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Benitec Biopharma stock.
The Eulerpool Quality Score for Benitec Biopharma is 1/10.
The ISIN of Benitec Biopharma is US08205P2092. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Benitec Biopharma is 722783. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Benitec Biopharma is BNTC. The ticker symbol is used to trade Benitec Biopharma shares on the stock exchange.
Benitec Biopharma stock
Benitec Biopharma Peer Group
Benitec Biopharma Ticker
All fundamentals and in-depth analysis of Benitec Biopharma
Our stock analysis for Benitec Biopharma stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Benitec Biopharma. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.